Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

DOD, VA, Congress Should Take Stronger Steps Toward Eliminating Tobacco Use In Military Populations, VA Medical Centers
Because tobacco use impairs military readiness, harms the health of soldiers and veterans, and imposes a substantial financial burden on the departments of Defense and Veterans Affairs, these agencies should implement a comprehensive strategy to achieve the Defense Department"s stated goal of a tobacco-free military, says a new report from the Institute of Medicine. DOD should gradually phase in a ban on tobacco use in the military, starting at military academies and officer training programs and among new recruits, the report says. DOD should also stop selling tobacco products in Army and Air Force commissaries -- Navy and Marine Corps commissaries already do not sell them -- and should stop selling them at a discount in military exchanges and other stores. In addition, Congress should allow VA to establish tobacco-free medical centers.
generic viagra online
MSF Calls For Humane Treatment, Medical Assistance To Migrants Displaced In Greece
Following yesterday"s police operation at a makeshift camp for migrants in Patras and the subsequent fire that broke out, Doctors Without Borders/Mç©decins Sans Frontiç¨res (MSF) expresses concern for the medical and humanitarian condition of the migrants and asylum seekers who were left homeless, as well as those who were arrested. MSF urges authorities to ensure humane living conditions and the provision of medical assistance to this population.
News of the day
Nexavar® In Combination With Chemotherapy Shown To Extend Progression-Free Survival In Patients With Advanced Breast Cancer
Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. announced that their first cooperative group-sponsored randomized Phase II trial in advanced metastatic breast cancer met its primary endpoint of progression-free survival. The study evaluated Nexavar® (sorafenib) tablets in combination with the oral chemotherapeutic, capecitabine, in patients with locally advanced or metastatic HER-2 negative breast cancer. Study findings demonstrated that the median progression-free survival was extended in patients treated with Nexavar and capecitabine compared to patients receiving capecitabine and placebo. These results were statistically significant (p-value = 0.0006). In this trial, the safety and tolerability of the combination was as expected and did not show any new or unexpected toxicities. A complete data analysis from this study is expected to be presented at an upcoming scientific meeting.
Medical Devices

The European Association For The Study Of The Liver Renews Publishing Partnership With Elsevier

Elsevier, the leading publisher of scientific, technical and medical information, is pleased to announce its renewed publishing partnership with The European Association for the Study of the Liver (EASL), the leading European association in the field of liver research. The agreement calls for Elsevier to publish the society"s flagship journal, the Journal of Hepatology, for the next five years. EASL is a society with over 1500 members. The society has given rise to a significant number of international clinical trials and research collaborations in liver disease for the benefit of patients all over the world. EASL"s flagship journal - the Journal of Hepatology - requires high standard quality contents and is highly perceived in its field. The journal publishes original papers, reviews, case reports and letters to the editor concerned with clinical and basic research in the field of hepatology. "I am thankful to work with a professional learned society and also very grateful for its support and input over the last years. I look forward to working with the newly appointed Editor-in-Chief, Professor Didier Samuel and his editorial team. The management and cure of, for instance, infectious liver diseases like Hepatitis B and C as well as the advanced search for the basic mechanisms of liver failure are major and global challenges of the 21st century. Elsevier is confident to make the Journal of Hepatology a continuing and growing success for authors, readers and for EASL" commented Koos Admiraal MD, Publisher for Elsevier. Koos Admiraal Elsevier


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009